Boston Scientific Corp <BSX.N>: Piper Sandler Cuts Target Price to $60 From $65
BSX•Related News
Netlist EVP, CFO Gail M. Sasaki sells 25,000 shares for $99,750
NLST•
Berkshire Hathaway Says 66% Of Aggregate Fair Value Of Equity Investments Was Concentrated In American Express, Apple, Bank Of America, Alphabet & Coca-Cola As Of June 30
BRK.B•
Nasdaq trade halt continues <SVA.O> reason not available at 03:28 AM
SVA•
Berkshire Q2 FY26 net earnings more than doubled to $25.67 billion
BRK.A•
Marcus & Millichap publishes investor presentation on CRE investment sales, financing brokerage strategy and 2025 performance
MMI•